PLX - Protalix BioTherapeutics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate-0.02-0.02-0.060.35
Low Estimate-0.04-0.04-0.150.26
High Estimate-0.0100.020.45
Year Ago EPS-0.06-0.08-0.18-0.06
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate10.15M11.4M45.85M105.44M
Low Estimate10M10.3M38.7M94.48M
High Estimate10.3M12.5M53M116.4M
Year Ago Sales4.55M2.01M34.24M45.85M
Sales Growth (year/est)122.90%468.30%33.90%130.00%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.09-0.06-0.04-0.04
EPS Actual-0.06-0.08-0.1-0.04
Difference0.03-0.02-0.060
Surprise %33.30%-33.30%-150.00%0.00%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.02-0.02-0.060.35
7 Days Ago-0.02-0.02-0.060.35
30 Days Ago-0.020.01-0.040.36
60 Days Ago-0.020.01-0.060.6
90 Days Ago-0.020.01-0.060.6
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/AN/AN/A
Up Last 30 Days1N/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A11N/A
Growth EstimatesPLXIndustrySectorS&P 500
Current Qtr.66.70%N/AN/A-0.02
Next Qtr.75.00%N/AN/A0.04
Current Year66.70%N/AN/A0.05
Next Year683.30%N/AN/A0.11
Next 5 Years (per annum)25.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A